Read the Original Investigation Cardioprotective Glucose-Lowering Agents and Dementia Risk. Read the Original Investigation GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias. Read the accompanying Editorial GLP-1 Receptor AgonistsFrom Breakthroughs in Cardiometabolic Treatment to Emerging Neuroprotective Potential. | JAMA Neurology
The STEP trials showed that stopping semaglutide led to substantial weight regain within 12 months
Our experts noted that itchy skin wasn't unheard of, but it certainly wasn't common
It can serve as a bridge between meals or support a more intentional morning routine
Total proteins were immunoblotted using an -HA antibody for detecting SUMM2 ac -HA (upper panel) and an -FLAG antibody for LET7-FLAG, LET7 TPR -FLAG, and LET7 PPase -FLAG (middle panel) with Ponceau S-stained RBC as loading controls (bottom panel)
Food: a simple plan you can follow Think balanced plate : non-starchy vegetables, protein, smart carbs (whole grains, fruit, beans), plus a thumb of healthy fat